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Cancer Mortality in Native Americans in North Carolina
RONNIE D. HORNER, PHD
Abstract: This paper describes age-adjusted mortality from
malignant neoplasms for Native Americans in North Carolina for
1968-72 and 1978-82. Sex-specific standardized mortality ratios were
calculated from death certificate data, using the cancer mortality
experience of White North Carolinians to obtain the number of
expected deaths. For most categories and specific sites of cancer,
mortality was at or below the expected level, but higher than
expected mortality was found for genitourinary cancers in males
Introduction
The epidemiology of cancer in Native American tribes in
the eastern United States is not well described. Studies ofthe
Seneca Nation in New York State found lower than expected
mortality from cancers of all sites for males and females of
this tribe. 1.2 In comparison to White residents of New York
State (exclusive of New York City), Seneca women had
lower mortality from cancers of the pancreas and breast, but
higher mortality from cervical cancer; Seneca men had
site-specific cancer mortality at or below the expected level.'
Native Americans nationally and in the Southwest show
a lower than expected overall cancer mortality and
incidence.34 Alaskan Native Americans experience a level of
mortality and incidence from all cancers which is similar to
White Americans.5-9 For specific sites, elevated mortality
(and incidence) is found for cancer of the gallbladder (par-
ticularly for females),37,'0-'3 esophagus and nasopharynx (for
Alaskan Native Americans),5,6.8'14,15 stomach,'6.17
cervix,3,5,81'8,'9 and multiple myeloma (in males).20 Signifi-
cantly lower mortality (and incidence) is found for lung
cancer,3,57,1'621 cancer of the female breast,6.7,8,16
melanomas,3.6 lymphomas and leukemias,20 pancreatic
cancer,3'16 colon cancer,3 and cancer of the prostate gland
(particularly for Eskimos and Aleuts).3.5-8 Alaskan Native
Americans have an increasing incidence of lung cancer for
both sexes; for females, esophageal and cervical cancers are
decreasing.67.79
This report describes cancer mortality in Native Amer-
icans in North Carolina for the 1968-72 and 1978-82 periods,
to gain insights into possible changes over time.
Methods
Native Americans in North Carolina are from several
tribes, including the Cherokee, Coharie, Eno-Occan-Eechee,
Haliwa-Saponi, Lumbee, Meherrin, Tuscardra, and Wacca-
maw-Sioun. The Cherokee in western North Carolina and the
Lumbee in the eastern region of the State are the largest
tribes. There has been considerable interbreeding between
Native Americans, Whites and, to a lesser extent, Blacks in
the region.22-25 As a consequence, there are few "full-
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(SMR = 1.62, 95% CI = 1.15, 2.2 1) for the 1978-82 period; within this
category, there was a higher than expected level of mortality from
prostate cancer (SMR = 2.00; 95% CI = 1.36, 2.83) and cancer of the
penis and other male genital organs (SMR = 9.09; 95% CI = 1.10,
32.84). Female Native Americans had an elevated mortality from
cervical cancer (SMR = 2.27, 95% CI = 1.09, 4.17) for the 1968-72
period only. (Am J Public Health 1990; 80:940-944.)
blooded" Native Americans in any of the tribes in the State.
Moreover, cancer mortality data by tribe are not available.
Population data for this study came from the 1970 and
1980 US census reports for North Carolina.26,27 Sixteen age
categories were used: <5 years old, 5-9, 10-14, . . ., 70-74,
and 75+ years of age. The distribution of Native Americans
by sex but not age was available for 1970, so the sex-specific
age distributions of Native Americans for 1980 were used to
estimate the 1970 age distributions.
Cancer mortality data were obtained from the detailed
mortality data tapes of the North Carolina State Center for
Health Statistics using the underlying cause of death for
North Carolina residents. Probably some Native Americans
were classified as White. (The magnitude of the racial
misclassification bias is currently under investigation: Per-
sonal communication from Dr. Tim E. Aldrich, director of
the Central Cancer Registry of North Carolina.)
The mortality data were classified according to the broad
categories of malignant neoplasms found in the International
Classification of Diseases (ICD) and by specific sites within
these categories.
The use of broad categories was necessary because the
data for specific cancer sites for Native Americans in North
Carolina were sparse. The use of broad categories also
reduced the effect of changes in the classification of cancers;
ICD-8 and ICD-9, though, are essentially identical for ma-
lignant neoplasms at the three-digit code level.
Specific sites identified by previous studies as being
above or below the expected level were also given attention.
The standardized mortality ratio (SMR) was calculated
using the 1980 age- and sex-specific cancer mortality rates of
White residents to obtain the expected number of deaths.
Although SMRs between different areas (times) usually
should not be compared because of different standards, the
identical age distribution in the Native American population
in 1970 and 1980 (for the reason described) and the use of the
same set of rates permit comparisons between time periods.28
In essence, the only difference between the 1970 and 1980
SMRs are the cancer mortality rates for Native Americans
which are reflected in the observed number of deaths. Cancer
deaths were assumed to follow a Poisson distribution. The
95% confidence intervals for the sex-specific SMRs were
calculated according to the approach described by Kahn and
Sempos.29
Results
The proportion of observed cancer deaths by category
among Native American and White residents of North
Carolina in 1968-72 and 1978-82 is shown in Table 1. For
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TABLE 1-Percentage Distribution of Deaths from Malignant Neoplasms, Native Americans and White
Residents of North Carolina, 1968-72 and 1978-82, by Sex and Category*
Native Americans Whites
Category of Malignancy
(ICD Code) 1968-72 1978-82 1968-72 1978-82
Males (n = 76) (n = 150) (n = 13,747) (n = 20,317)
Lip, Oral Cavity, and Pharynx
(140-149) 1.3 2.7 3.3 2.3
Digestive Organs and
Peritoneum (150-159) 27.6 19.3 22.5 21.5
Respiratory and Intrathoracic
Organs (160-165) 19.7 30.0 32.8 38.2
Bone, Connective Tissue, Skin,
and Breast (170-175) 1.3 0.7 3.7 3.2
Genitourinary Organs
(179-189) 23.7 26.0 14.8 14.4
Lymphatic and Hematopoietic
Tissue (200-208) 14.5 11.3 11.1 9.2
Other and Unspecified Sites
(1 9-199) 11.8 10.0 11.8 11.3
Females (n = 44) (n = 89) (n = 11,268) (n = 16,285)
Lip, Oral Cavity, and Pharynx
(140-149) 2.3 3.4 2.0 1.6
Digestive Organs and
Peritoneum (150-159) 18.2 27.0 25.5 25.2
Respiratory and Intrathoracic
Organs (160-165) 2.3 3.4 7.3 13.8
Bone, Connective Tissue, Skin,
and Breast (170-175) 18.2 19.1 22.7 22.1
Genitourinary Organs
(179-189) 36.4 19.1 18.4 14.7
Lymphatic and Hematopoietic
Tissue (200-208) 9.1 13.5 10.8 10.2
Other and Unspecified Sites
(190-199) 13.6 14.6 13.2 12.4
TPercentages may not sum to 100% due to rounding.
White residents ofboth sexes, the proportion of cancer deaths
within each category is fairly stable between the two periods.
Among male Native Americans, deaths from cancer of the
digestive organs and peritoneum decreased, but deaths from
cancers of the respiratory and intrathoracic organs increased.
For female Native Americans, deaths from cancers of the
digestive organs and the peritoneum increased, but genitouri-
nary cancer deaths decreased. None of the differences be-
tween time periods were statistically significant.
As Table 2 shows, Native Americans experienced a
generally lower or equal level of mortality from the various
cancers to that expected based on the experience of White
North Carolinians. The only clearly elevated SMR is for
genitourinary neoplasms in male Native Americans for the
1978-82 period (SMR = 1.62, 95% CI = 1.15, 2.21); the SMR
for this category is also elevated for 1968-72.
The SMRs in Table 2 suggest that changes in cancer
mortality for Native Americans may have occurred between
1968-72 and 1978-82. There is an increase in the number of
cancer deaths for Native American females from significantly
below to near the expected levels for digestive organ and
peritoneum cancers. A similar change occurs for respiratory
and intrathoracic cancer mortality for male Native Ameri-
cans. Also as noted previously, deaths from genitourinary
cancers increased from a level similar to the expected number
to a higher number for male Native Americans. Both sexes
may also be experiencing an increase in cancers of the lip,
oral cavity, and pharynx.
Table 3 shows the SMRs associated with specific cancer
sites which have been identified as having significantly above
or below expected mortality for Native Americans. The
SMRs for each three-digit site are available on request to the
author. Most deaths from cancer at the various anatomic sites
are at levels similar to that found among White residents of
North Carolina. Deaths from cancer of the breast and colon
are lower than expected in both time periods for females.
Mortality from cancer ofthe cervix uteri was more than twice
that of Whites in 1968-72 and in 1978-82. A slight increase in
mortality from prostatic cancer is indicated; and rates are
elevated in both periods. Mortality from cancer of the penis
and other male genital organs (ICD 187) is also significantly
elevated in both periods.
Discussion
The Native Americans in this report represent several
tribes which have bred extensively with other racial groups,
and yet their cancer mortality experience generally follows
that of Native Americans elsewhere in the nation, with lower
than expected mortality from cancers of all sites, respiratory
and intrathoracic cancers, and cancers of the female breast,
but a higher than expected mortality for cancer of the cervix
uteri. The higher mortality from prostate cancer seen in this
study was also found for Alaskan Indians.3,5,6.8 A unique
finding of this study is the elevated mortality from cancer of
the penis and other male genital organs (ICD 187). Unlike
Alaskan Native Americans, no nasopharynx cancers were
reported in either study period. Nor was there a higher than
expected mortality from cancers of the gallbladder and
stomach which are common in tribes of the Southwest.
Clearly elevated mortality in North Carolinian Native
Americans was found only for cancers of the prostate, male
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TABLE 2-Standardized Mortality Ratios (95% Cl) for Malignant Neoplasms, Native American Residents of
North Carolina, 1968-72 and 1978-82, by Sex and Category
Category of Malignancy
(ICD Code)
All Sites (140-208)
Lip, Oral Cavity and
Pharynx (140-149)
Digestive Organs and
Peritoneum (150-159)
Respiratory and
Intrathoracic Organs
(160-165)
Bone, Connective Tissue,
Skin, and Breast
(170-175)
Genitourinary Organs
(179-189)
Lymphatic and
Hematopoietic Tissue
(200-208)
Other and Unspecified
Sites (190-199)
Males
1968-72
(95% Cl)
0.79
(0.62, 0.99)
0.32
(0.01, 1.80)
1.02
(0-63, 1.57)
0.48
(0.27, 0.79)
0.25
(0.01, 1.38)
1.39
(0.82, 2.20)
0.92
(0.46, 1.64)
0.74
(0.34, 1.41)
Females
1978-82
(95% Cl)
0.87
(0.73, 1.02)
1.02
(0.28, 2.61)
0.80
(0.53, 1.14)
0.70
(0.51, 0.94)
0.16
(0.004, 0.90)
1.62
(1.15, 2.21)
0.85
(0.47,1.40)
0.83
(0.48, 1.33)
1968-72
(95% Cl)
0.54
(0.39, 0.73)
0.64
(0.02, 3.57)
0.41
(0.18, 0.82)
0.17
(0.004, 0.94)
0.42
(0.18, 0.82)
1.06
(0.61, 1.72)
0.42
(0.12, 1.09)
0.55
(0.20, 1.20)
1978-82
(95% Cl)
0.71
(0.57, 0.87)
1.61
(0.33, 4.71)
0.85
(0.54, 0.98)
0.17
(0.03, 0.49)
0.57
(0.33, 0.91)
0.93
(0.54, 1.48)
0.91
(0.47,1.59)
0.84
(0.44, 1.43)
TABLE 3-Standardized Mortality Ratios (95% Cl) for Selected Malignant Neoplasms, Native American
Residents of North Carolina, 1968-72 and 1978-82, by Sex
Males Females
1968-72 1978-82 1968-72 1978-82
Site of Malignancy (ICD Code) (95% Cl) (95% Cl) (95% Cl) (95% Cl)
Nasopharynx (147) 0.00 0.00 0.00 0.00
(0.00, 12.30) (0.00,11.53) (0.00, 26.34) (0.00, 23.06)
Esophagus (150) 0.00 0.97 1.16 3.57
(0.00, 2.20) (0.20, 2.83) (0.03, 6.48) (0.93, 9.14)
Stomach (151) 1.42 1.60 0.82 1.47
(0.46, 3.31) (0.64, 3.29) (0.10, 2.96) (0.40, 3.77)
Colon (153) 0.64 0.38 0.24 0.31
(0.17, 1.63) (0.12, 0.88) (0.03, 0.87) (0.08, 0.79)
Gallbladder (156) 0.00 0.00 0.84 2.42
(0.00, 5.76) (0.00, 3.80) (0.02, 6.07) (0.50, 7.07)
Pancreas (157) 1.93 1.00 0.52 0.95
(0.93, 3.55) (0.46, 1.90) (0.06, 1.88) (0.35, 2.08)
Trachea, Bronchus or Lung (162) 0.44 0.71 0.18 0.17
(0.23, 0.75) (0-52, 0.96) (0.005, 1.01) (0.04, 0.51)
Breast, Female (174) - - 0.37 0.59
(0.13, 0.77) (0.34, 0.99)
Cervix Uteri (180) - - 2.27 2.30
(1.09, 4.17) (0.99, 4.53)Prostate (185) 1.70 2.00
(0.91, 2.91) (1.36, 2.83)
Penis and other male genital
organs (187) 22.22 9.09 - -
(2.69, 80.27) (1.10, 32.84)
Lymphomas (200-202) 0.46 0.30 0.28 0.84
(0.06, 1.65) (0.04, 1.10) (0.01, 1.56) (0.23, 2.16)
Multiple Myeloma (203) 0.72 1.48 0.00 1.98
(0.02, 4.04) (0.40, 3.24) (0.00, 3.32) (0.54, 5.07)
Leukemias (204-208) 1.28 1.07 0.56 0.63
(0.55, 2.53) (0.49, 2.03) (0.12, 1.64) (0.17,1.60)
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genitalia, and the cervix. Prostatic and penile cancers are
more prevalent in Blacks than either Whites or Native
Americans generally.30'31 However, the racial mixing in
Native Americans of North Carolina is unlikely to account
for their unexpectedly higher mortality from these cancers
because the Black contribution to the genetic pool of most
tribes of the Carolinas is indicated to be minimal.22-25 Diet
may be involved in cancer of the prostate. Although contro-
versial, there is epidemiologic evidence of a positive associ-
ation between prostatic cancer and a diet high in fats and
vitamin A, particularly in older males.32-35 However, an
inverse association between the level of consumption of
green and yellow vegetables (and hence vitamin A) and
prostatic cancer is found for Japanese males.36 Dietary
information on North Carolinian Native Americans is not
available. The elevated mortality from cervical cancer may
indicate a low level of cervical cancer screening among
Native American females in North Carolina. An inverse
association between extent of cervical cancer screening in
populations and mortality from cancer of the cervix is
reported for Native Americans elsewhere.18,19
There is indication that the cancer mortality experience
of North Carolinian Native Americans may be worsening,
which would suggest that the lower than expected cancer
mortality for Native Americans is more strongly related to
environmental factors than to genetics. Although the number
of cases is too few for definitive conclusions, an increase in
mortality may be occurring from: cancer of the lip, oral
cavity, and pharynx for both sexes; cancers ofthe respiratory
and intrathoracic organs, and genitourinary organs for males;
and cancers of the digestive organs and peritoneum for
females. For specific sites, an increase in mortality may be
occurring for cancer of the prostate and the trachea, bron-
chus, and lung for males. It has been suggested that lung
cancer mortality is increasing in Alaskan Native Americans
as well.6,7 Information on the use of tobacco products such
as snuff and chewing tobacco by Native Americans in North
Carolina is not available, although several reports indicate
high prevalence of tobacco use among younger Native
Americans elsewhere.3740
It is recognized that the patterns reported in this study
may reflect several biases. There is the possibility of racial
misclassification bias in the mortality statistics, although its
presence and magnitude have yet to be determined. More-
over, the age-specific population data for Native Americans
in 1970 are only estimates. Diagnostic bias may also be
present; however, the proportion of "other and unspecified"
cancers has remained stable over time. The data also reflect
coding under the eighth and ninth ICD; however, the two
revisions are essentially identical for neoplasia. Perhaps of
more concern, the data were aggregated across tribes which
could obscure patterns of cancer mortality within tribes.
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I HUD Issues Guidelines on Lead-Based Paint Abatement I
The US Department of Housing and Urban Development (HUD) has issued the first federal
guidelines for the identification and abatement of lead-based paint in all public and Indian housing
developments. The interim guidelines, signed by HUD Secretary Jack Kemp and published in the
Federal Register, became effective April 1 and apply to all rehabilitation programs in public housing from
that date forward.While the guidelines are recommendations and not mandatory, they represent the first
national technical rules and procedures for testing, abatement worker protection, clean-up and disposal
of lead-based paint in residential structures. The standards outlined in the 160-page document include
several procedures for lead paint testing and removal that have proven effective in cities where lead
abatement programs are mandated, such as Baltimore and Boston. Lead-based paint is believed to exist
in about 40 million homes, or 40 percent of the country's housing stock where lead paint was used prior
to 1970.
The federal guidelines recommend three accepted abatement strategies: complete replacement of
all lead-painted surfaces, encapsulation or sealing of lead-painted areas, or paint removal. The guidelines
outline the various methods of paint stripping, sanding and chemical processing, and the appropriate
precautions to be taken with each, including daily and final clean-up. Proper clean-up procedures involve
a thorough vacuuming, using a High Efficiency Particulate Air (HEPA)-filtered vacuum, followed by wet
wiping with a high-phosphate solution, followed by a second HEPA vacuuming. The guidelines also
recommend that sanding flat surfaces should be done with a sander attached to a HEPA vacuum that
can collect the dust particles as they are released. Nilfisk of America, Inc., of Malvem, PA, one of the
nation's leading manufactures of HEPA-filtered vacuums used in removal of lead, asbestos, silica,
fiberglass and other harmful dusts, was asked by the National Institute of Building Sciences to
participate in drafting the rules and recommendations that formed the basis for HUD's interim
guidelines. For further information, contact HUD Headquarters, 451 7th Street, SW, Washington, DC
20410. Tel: (202) 755-6422.
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